Abstract
Purpose
This study analyzed the late ear complications of radiotherapy for nasopharyngeal cancer (NPC) and compared the conventional and intensity-modulated radiotherapy (2D-RT and IMRT, respectively).
Methods
At 2–21 years after the end of NPC treatment, 104 ears of 52 patients were evaluated with the otoscopic examination, pure tone audiometry test, tympanometry, and subjective complaints by being blinded to the radiotherapy technique.
Results
There were no differences in terms of the pathology of the external, middle or inner ear, air and bone-conduction hearing thresholds, and the air–bone (A–B) gap at 500, 1000, 2000, and 4000 Hz, and tympanometry types between 2D-RT and IMRT groups (p > 0.05). There were positive correlations between the values of A500 and A1000 thresholds; gap 500, 4000, and mean cochlear RT dose (p < 0.05). There were positive correlations between the values of A500, A1000, and A4000 thresholds; gap 500, 1000, 2000, 4000, and maximum cochlear RT dose (p < 0.05).
Conclusion
IMRT was not found to be superior to 2D-RT to prevent RT-induced ear complications. The solution of the middle ear problems must be the goal of the strategies for complications treatment.
Similar content being viewed by others
References
Jeyakumar A, Brickman TM, Jeyakumar A, Doerr T (2006) Review of nasopharyngeal carcinoma. ENT Ear Nose Throat J 85:168–173
Low WKC, Rangabashyam M (2012) Ear-related issues in patients with nasopharyngeal carcinoma. In: Carcinogenesis, diagnosis, and molecular targeted treatment for nasopharyngeal carcinoma. InTech, Croatia, pp 155–178
Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R (2003) Radiotherapy-induced ear toxicity. Cancer Treat Rev 29(5):417–430
Menzel HG (2014) International commission on radiation units and measurements. J ICRU 14(2):1–2
Sumitsawan Y, Chaiyasate S, Chitapanarux I, Anansuthiwara M, Roongrotwattanasiri K, Vaseenon V, Tooncam H (2009) Late complications of radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 36(2):205–209
Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM (2010) Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 76(3):50–57
Fleury B, Lapeyre M (2010) Tolerance of normal tissues to radiation therapy: ear. Cancer Radiother 14(4–5):284–289
Wang X, Hu C, Eisbruch A (2011) Organ-sparing radiation therapy for head and neck cancer. Nat Rev Clin Oncol 8(11):639
Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66(4):981–991
Hwang CF, Fang FM, Zhuo MY, Yang CH, Yang LN, Hsieh HS (2015) Hearing assessment after treatment of nasopharyngeal carcinoma with CRT and IMRT techniques. BioMed Res Int 2015:769806. https://doi.org/10.1155/2015/769806
Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK et al (2009) Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 73(5):1335–1342
Li JJ, Guo YK, Tang QL, Li SS, Zhang XL, Wu PA, Yang XM (2010) Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol 124(1):32–36
Wang LF, Kuo WR, Ho KY, Lee KW, Lin CS (2004) A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otol Neurotol 25(2):168–173
Wakisaka H, Yamada H, Motoyoshi K, Ugumori T, Takahashi H, Hyodo M (2011) Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 38(1):95–100
Hsin CH, Chen TH, Young YH, Liu WS (2010) Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients. Otolaryngol Head Neck Surg 143(5):662–668
Zeng L, Tian YM, Sun XM, Chen CY, Han F, Xiao WW et al (2014) Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors. Br J Cancer 110(1):49
Liang KL, Su MC, Twu CW, Jiang RS, Lin JC, Shiao JY (2011) Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 268(2):213–217
Yao JJ, Zhou GQ, Lin L, Zhang WJ, Peng YL, Chen L et al (2015) Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma. Sci Rep 5:13525
Lou PJ, Chen WP, Tai CC (1999) Delayed Irradiation effects on nasal epithelium in patients with nasopharyngeal carcinoma; an ultrastructural study. Ann Otol Rhinol Laryngol 108(5):474–480
Zhou Y, Tang A, Li J, Chen P, Mao R (2003) The damaged types of eustachian tube function in the patients of nasopharyngeal carcinoma after radiotherapy. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17(8):464–465
Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, Au DK (1999) Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study. Head Neck J Sci Spec Head Neck 21(6):547–553
Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT et al (1996) Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Rad Oncol Biol Phys 36(2):281–289
Raaijmakers E, Engelen AM (2002) Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 65(1):1–7
Bohne BA, Marks JE, Glasgow GP (1985) Delayed effects of ionizing radiation on the ear. Laryngoscope 95(7):818–828
Low WK, Burgess R, Fong KW, Wang DY (2005) Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 115(10):1823–1826
Mujica–Mota M, Waissbluth S, Daniel SJ (2013) Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: A systematic review. Head neck 35(11):1662–1668
Low WK, Tan MG, Chua AW, Sun L, Wang DY (2009) 12th Yahya cohen memorial lecture—the cellular and molecular basis of radiation-induced sensori-neural hearing loss. Ann Acad Med Singap 38(1):91
Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM (2007) Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 67(2):469–479
Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY (2006) Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 24(12):1904–1909
Liberman PHP, Schultz C, Gomez MVSG, Carvalho AL, Pellizzon ACA, Testa JR et al (2004) Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 130(11):1265–1268
Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH et al (2007) Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol Biol Phys 68(5):1320–1325
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Rights and permissions
About this article
Cite this article
Ant, A., Yazici, Ö., Atabey, P. et al. Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?. Eur Arch Otorhinolaryngol 276, 977–984 (2019). https://doi.org/10.1007/s00405-019-05299-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05299-7